BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• BRCA2 is crucial for replication fork stability.
• BRCA2 deficiency leads to genomic instability.
• The precise mechanisms driving this instability are not fully understood.

Purpose of the Study:

• To identify key drivers of genomic instability in BRCA2-deficient cells.
• To elucidate the role of APOBEC3B in BRCA2 loss-associated DNA damage.
• To explore the therapeutic potential of targeting APOBEC3B, UNG2, and APE1.

Main Methods:

• Utilized a novel uracil-in-DNA probe to detect DNA lesions.
• Investigated the impact of BRCA2 loss on APOBEC3B activity and DNA repair pathways.
• Assessed the effects of depleting APOBEC3B, UNG2, and APE1.
• Correlated gene expression with patient survival data.

Main Results:

• BRCA2 loss promotes APOBEC3B-mediated uracil accumulation at stalled replication forks.
• This uracil accumulation triggers fork collapse and activates NF-κB signaling, upregulating APOBEC3B.
• Depletion of APOBEC3B, UNG2, or APE1 rescues genomic instability.
• BRCA1-deficient cells do not exhibit these APOBEC3B-dependent defects.
• Low APE1 and high APOBEC3 expression correlate with poor survival in BRCA2-mutant tumors.

Conclusions:

• APOBEC3B is a key driver of genomic instability in BRCA2-deficient cells.
• A self-reinforcing loop involving APOBEC3B, uracil accumulation, and DNA repair exacerbates DNA damage.
• Targeting APOBEC3B, UNG2, or APE1 may represent a therapeutic strategy for BRCA2-mutant cancers.
• BRCA2 deficiency confers a specific vulnerability to APOBEC3B-driven mutagenesis.